91 related articles for article (PubMed ID: 3554591)
21. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
[TBL] [Abstract][Full Text] [Related]
22. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
Yeomans ND
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
[TBL] [Abstract][Full Text] [Related]
23. [Clinical experimental ground of positive influence of hypotensive drugs on defect of the gastric mucosa in stomach ulcer].
Mikheeva OM; Lazebnik LB; Belostotskiĭ NI; Khomeriki SG
Eksp Klin Gastroenterol; 2007; (5):11-20. PubMed ID: 18389592
[No Abstract] [Full Text] [Related]
24. [Dynamics of the recurrence of chronic ulcer and the state of the gastric mucosa].
Pokrotniek IuIa; Strelis EA; Kalinka RF; Skuia NA
Ter Arkh; 1983; 55(2):15-7. PubMed ID: 6845193
[No Abstract] [Full Text] [Related]
25. The gastroprotective effect of tannins extracted from duhat (Syzygium cumini Skeels) bark on HCl/ethanol induced gastric mucosal injury in Sprague-Dawley rats.
Ramirez RO; Roa CC
Clin Hemorheol Microcirc; 2003; 29(3-4):253-61. PubMed ID: 14724349
[TBL] [Abstract][Full Text] [Related]
26. A comparative dynamic study of the effectiveness of gastric cytoprotection by vitamin A, De-Nol, sucralfate and ulcer healing by pirenzepine in patients with chronic gastric ulcer (a multiclinical and randomized study).
Patty I; Tárnok F; Simon L; Jávor T; Deák G; Benedek S; Kenéz P; Nagy L; Mózsik G
Acta Physiol Hung; 1984; 64(3-4):379-84. PubMed ID: 6397969
[TBL] [Abstract][Full Text] [Related]
27. [The role of the enzymatic antioxidant system and Helicobacter pylori infection in the pathogenesis of peptic ulcer and their effect on treatment efficacy].
Esedov EM; Muradova VR; Mamaev SN
Ter Arkh; 1999; 71(2):19-22. PubMed ID: 10222547
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and morphological characteristics of ulcer in elderly patients].
Cherniaev AIa
Eksp Klin Gastroenterol; 2002; (2):18-21. PubMed ID: 12046378
[No Abstract] [Full Text] [Related]
29. [Prognosis of chronic stomach ulcer according to the results of gastrochromoscopic morphologic evaluation of the gastric mucosa].
Pokrotniek IuIa; Strelis EA; Pominova VB; Sitkin SI; Skuia NA
Ter Arkh; 1986; 58(2):45-8. PubMed ID: 3704938
[TBL] [Abstract][Full Text] [Related]
30. [Complex treatment of patients with non-healing stomach ulcers using hyperbaric oxygenation].
Preobrazhenskiĭ VN; Seroshtanova AF; Kirillov VA; Kasatkin NN; Malkov DB
Klin Med (Mosk); 1989 May; 67(5):77-80. PubMed ID: 2770216
[TBL] [Abstract][Full Text] [Related]
31. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
32. A method of inducing chronic gastric and duodenal ulcer by electrocoagulation in rats.
Małecki I
Acta Physiol Pol; 1983; 34(5-6):531-7. PubMed ID: 6679989
[TBL] [Abstract][Full Text] [Related]
33. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
Pal'tsev AI; Maslennikova TA
Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582
[No Abstract] [Full Text] [Related]
34. Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharide-induced gastric ulcer in rats.
Devi RS; Kist M; Vani G; Devi CS
J Pharm Pharmacol; 2008 Apr; 60(4):505-14. PubMed ID: 18380924
[TBL] [Abstract][Full Text] [Related]
35. [A method for stimulating the protective mechanisms of the gastric mucosa in peptic ulcer].
Iakubov AV; Usmanov RI; Khakimov ZZ
Eksp Klin Farmakol; 1997; 60(2):30-2. PubMed ID: 9206565
[TBL] [Abstract][Full Text] [Related]
36. Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate.
Karita M; Morshed MG; Ouchi K; Okita K
Am J Gastroenterol; 1994 Jul; 89(7):1032-5. PubMed ID: 8017361
[TBL] [Abstract][Full Text] [Related]
37. [Campylobacter pylori, gastritis and peptic ulcer].
Hirschl AM; Stanek G; Rotter M; Pötzi R; Gangl A; Hentschel E; Schütze K; Holzner HJ; Nemec H
Wien Klin Wochenschr; 1987 Jul; 99(14):493-7. PubMed ID: 3630180
[TBL] [Abstract][Full Text] [Related]
38. [Clinical pathomorphology of the liver and gastric mucosa in peptic ulcer complications].
Khmel'nitskii OK; Ryskulova KR; Tararak TIa
Vestn Khir Im I I Grek; 1981 Apr; 126(4):37-41. PubMed ID: 7269073
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo anti-Helicobacter pylori activity of Calophyllum brasiliense Camb.
Souza Mdo C; Beserra AM; Martins DC; Real VV; Santos RA; Rao VS; Silva RM; Martins DT
J Ethnopharmacol; 2009 Jun; 123(3):452-8. PubMed ID: 19501278
[TBL] [Abstract][Full Text] [Related]
40. [The characteristics of peptic ulcer in subjects with concomitant ischemic heart disease].
Loginov AS; Zvenigorodskaia LA; Potapova VB; Arbuzova VG; Korzhikov VV; Nilova TV
Ter Arkh; 1998; 70(2):9-13. PubMed ID: 9551561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
